IP Verse

Biogaran patent opposition analysis

Get complete Patent Opposition Report for Biogaran

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Biogaran

Explore patent oppositions filed by Biogaran against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3345604	Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations	H LUNDBECK	Mar 6, 2024
EP3578175	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Aug 30, 2023
EP2653873	Compositions And Uses For Treating Multiple Sclerosis	BIOGEN IDEC MA	Apr 20, 2023
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Jan 13, 2023
EP2478907	Methods And Compositions For Treating Cancer	COUGAR BIOTECHNOLOGY	Jan 14, 2022
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 23, 2021
EP3395338	Rapid Dissolution Formulation Of Cinacalcet Hcl	AMGEN	Jan 31, 2020
EP3260117	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Jan 17, 2020
EP3395339	Rapid Dissolution Formulation Of A Cinacalcet Hcl	AMGEN	Jan 17, 2020
EP3395340	Rapid Dissolution Formulation Of Cinacalcet Hcl	AMGEN	Jan 17, 2020

Top competitors of Biogaran

AMGEN

NOVARTIS

JANSSEN PHARMACEUTICA